GLP-1 is contraindicated in patients including but not limited to: those with a personal or family history of medullary thyroid cancer, patients with multiple endocrine neoplasia type 2, patients with a hypersensitivity reaction to GLP-1 or any of the product components, as well as patients with pancreatitis, kidney disease, diabetic retinopathy or gallbladder disease
The SeekPeptides peptide calculator can help you determine exact dosing based on your vial concentration and prescribed dose
But type 1 diabetics, especially those with obesity, often have insulin resistance and thus many of the same health issues as those with type 2 for example, nerve damage , foot ulcers and eye damage, all due to uncontrolled blood sugar
What happens if 40 units doesn't produce the desired effect
Alogliptin Attenuates Lipopolysaccharide-Induced Neuroinflammation in Mice Through Modulation of TLR4/MYD88/NF-kappaB and miRNA-155/SOCS-1 Signaling Pathways